The CARES Initiative Making the Move to Mealtime Insulin in Type 2 Diabetes: A Patient-Centered Approach

FACULTY

Kathleen Dungan, MD, MPH
Professor of Internal Medicine
The Ohio State University
Division of Endocrinology, Diabetes & Metabolism
Columbus, OH

Javier Morales, MD, FACP, FACE
Associate Clinical Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Vice President, Principal Clinical Trial Investigator
Advanced Internal Medicine Group
East Hills, NY

PROGRAM OVERVIEW

This online educational program focuses on the latest data on mealtime insulin in patients with type 2 diabetes mellitus. In this program, clinicians will address appropriate treatment intensification strategies in consideration of patient-related factors, the latest clinical data, and key parameters for monitoring clinical response to mealtime insulin. Through this program, clinicians will improve their level of comfort with initiating mealtime insulins to optimize glycemic outcomes, including in underserved populations. Innovative learning strategies will reinforce the latest best practices to support clinician and patient understanding of the latest strategies in glycemic management.

TARGET AUDIENCE

This educational activity is intended for U.S. primary care physicians, nurse practitioners, physician assistants, and Diabetes Care and Education Specialists (DCES), with emphasis on those who provide care to underserved communities and who have the greatest needs.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Evaluate strategies for facilitating timely treatment intensification in patients with T2DM
• Determine which patients are poised to benefit from the use of mealtime insulin
• Select among mealtime insulin formulations based on their pharmacological profiles and patient needs
• Apply measures such as time in range (TIR), postprandial glucose (PPG), and insulin dosing information to treatment decisions for patients with T2DM

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with Type 2 Diabetes.
CNE Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Dungan is a consultant for Eli Lilly, Dexcom, and Elsevier, conducted research for Dexcom, Abbott, Sanofi, Novo Dordisk and ViaCyte, Dr. Dungan has received royalty from UpToDate, and has served on the speaker’s bureau for the Academy for Continued Healthcare Learning, and Cardiometabolic health conference.

Dr. Morales is a consultant for Novo Nordisk, Boehringer Ingelheim, Eli Lilly, Bayer, and Zealand. He is a member of a Speakers Bureau for Novo Nordisk, Boehringer Ingelheim, Eli Lilly, Bayer, and Amgen. He has also conducted research for Novo Nordisk.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Michael Page, PharmD, Medical Director for Med Learning Group, discloses an ownership stake in Advantific, LLC.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
• Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
• Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
• Morgan Kravarik, Associate Program Manager for Med Learning Group, has nothing to disclose.
• Rashado Coote, Program Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures
2. Participate in the online activity
3. Complete pre-and-post surveys and evaluation

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/.

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: October 14, 2022
EXPIRATION DATE: October 14, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.